371 results on '"Roh, Jee Hoon"'
Search Results
52. P3-092: IPSC MODELING OF PSEN1 MUTATION IN ALZHEIMER'S DISEASE WITH CEREBELLAR ATAXIA
53. P4-294: THE CLINICAL FEASIBILITY OF DEEP LEARNING BASED CLASSIFICATION OF AMYLOID PET IMAGE IN VISUALLY EQUIVOCAL CASES
54. The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction
55. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system
56. Qualitative Comparison of Semantic Memory Impairment in Patients with Amnestic Mild Cognitive Impairment Based on β-Amyloid Status
57. Comparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
58. iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia
59. Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias
60. P3‐089: DATA‐DRIVEN PATHOLOGICAL POSITIVITY OF ALZHEIMER DISEASE: AN EXPLORATORY STUDY OF DYNAMIC BIOMARKER CAUSALITY
61. P2‐236: SLEEP CHANGES IN ALZHEIMER'S DISEASE SPECTRUM DISORDERS MEASURED BY A PORTABLE POLYSOMNOGRAPHY
62. P1‐396: COGNITION AND NEUROFIBRILLARY DEGENERATION IN PATIENTS WITH AMYLOID‐NEGATIVE MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
63. P2‐359: RELATION NETWORKS OF NEURODEGENERATION IN ALZHEIMER'S DISEASE SPECTRUM: TAU, AMYLOID, AND CORTICAL ATROPHY
64. P3‐433: NEURAL SUBSTRATES OF COGNITIVE RESERVE IN THE ALZHEIMER'S DISEASE SPECTRUM
65. One year longitudinal change of tau accumulation on [18F]PI‐2620 PET in Alzheimer spectrum.
66. PATTERNS OF REGIONAL TAU ACCUMULATION INDICATIVE OF THREE DIFFERENT TYPES OF ALZHEIMER'S DISEASE (AD): THK5351-PET-BASED REPLICATION OF PATHOLOGY-BASED AD CLASSIFICATION
67. [P1-454]: POSITIVE ASSOCIATION BETWEEN EDUCATION AND THK-5351 UPTAKES IN PATIENTS WITH ALZHEIMER's DISEASE
68. [P2-406]: IN VIVO BRAAK STAGING OF AMNESTIC MCI USING 18 F-THK5351 PET IMAGING
69. [P2-361]: SURFACE-BASED ANALYSIS OF SUB-CORTICAL STRUCTURES IN TAU AND AMYLOID PET IMAGING: AN ALZHEIMER'S DISEASE STUDY
70. [P3-337]: THK5351 UPTAKES IN EARLY AND LATE STAGES OF AMNESTIC MILD COGNITIVE IMPAIRMENT
71. [P3-430]: GASTROINTESTINAL MICROBIOME STATUS OF EARLY ONSET ALZHEIMER's DISEASE (EOAD) AND FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) SUBJECTS
72. [P3-319]: MILD COGNITIVE IMPAIRMENT CLASSIFICATION USING DEEP LEARNING
73. [P2-424]: PROTECTIVE EFFECTS OF EDUCATION ON THK-5351 UPTAKES IN MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON-ALZHEIMER PATHOLOGY
74. [P3-383]: REGIONAL CANONICAL ASSOCIATION OF AMYLOID-BETA AND GLUCOSE METABOLISM SUGGESTIVE OF EARLY BRAIN DYSFUNCTIONS IN NORMAL ELDERLY WITH APOEε4 ALLELE
75. [P1-132]: IMPROVEMENT OF CORTICAL THICKNESS COMPATIBILITY BETWEEN DIFFERENT MRI T1 PROTOCOLS BY W-SCORE STANDARDIZATION
76. [P4-253]: QUANTITATIVE ANALYSIS AND CORRELATION WITH COGNITIVE FUNCTION OF F-18 THK-5351 PET IN SUBJECTIVE MEMORY IMPAIRMENT, MILD COGNITIVE IMPAIRMENT, AND ALZHEIMER's DISEASE
77. [P4–046]: PARTIAL VOLUME SUSCEPTIBILITY OF TAU PET: REGIONWISE ASSESSMENT AND COMPARISON WITH AMYLOID PET
78. [P1-129]: PREDICTION MODEL OF TAU PROPAGATION IN AD SPECTRUM USING FUNCTIONAL NETWORK
79. Comparison of Amyloid β and Tau Spread Models in Alzheimer's Disease.
80. Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias.
81. THE CLINICAL FEASIBILITY OF DEEP LEARNING BASED CLASSIFICATION OF AMYLOID PET IMAGE IN VISUALLY EQUIVOCAL CASES
82. P4-183: Regional Amyloid Burden and Lacunar Infarct in Pure Subcortical Vascular Cognitive Impairment
83. O3-02-06: Regional Comparison of Imaging Biomarkers in the Striatum Between Early Versus Late-Onset Alzheimer’s Disease
84. P4-197: Clinical Implication of Amyloid-Beta Accumulation in Occipital Lobes Using a [18F]-Florbetaben PET
85. White Matter Changes May Precede Gray Matter Loss in Elderly with Subjective Memory Impairment
86. Human Herpes Virus 6 Encephalitis Following Bone Marrow Transplantation with Uncommon Magnetic Resonance Imaging Findings
87. NEURAL SUBSTRATES OF COGNITIVE RESERVE IN THE ALZHEIMER’S DISEASE SPECTRUM
88. DATA-DRIVEN PATHOLOGICAL POSITIVITY OF ALZHEIMER DISEASE: AN EXPLORATORY STUDY OF DYNAMIC BIOMARKER CAUSALITY
89. RELATION NETWORKS OF NEURODEGENERATION IN ALZHEIMER’S DISEASE SPECTRUM: TAU, AMYLOID, AND CORTICAL ATROPHY
90. SLEEP CHANGES IN ALZHEIMER'S DISEASE SPECTRUM DISORDERS MEASURED BY A PORTABLE POLYSOMNOGRAPHY
91. COGNITION AND NEUROFIBRILLARY DEGENERATION IN PATIENTS WITH AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE
92. Sleep-wake cycle and diurnal fluctuation of amyloid-β as biomarkers of brain amyloid pathology
93. The neural correlates of motor intentional disorders in patients with subcortical vascular cognitive impairment
94. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease
95. Is there a link between the sleep–wake cycle and Alzheimer's pathology?
96. Effect of Midazolam on Memory During Fiberoptic Gastroscopy Under Conscious Sedation
97. A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
98. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease
99. PROTECTIVE EFFECTS OF EDUCATION ON THK-5351 UPTAKES IN MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON-ALZHEIMER PATHOLOGY
100. IN VIVO BRAAK STAGING OF AMNESTIC MCI USING 18F-THK5351 PET IMAGING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.